Resona Asset Management’s AbbVie ABBV Stock Holding History

Resona Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$132M	Sell	525,318 -40,090	-7%	-$8.63M	0.62%	26
2026 Q1	$122M	Buy	565,408 +10,331	+2%	+$2.29M	0.61%	23
2025 Q4	$127M	Sell	555,077 -24,330	-4%	-$5.54M	0.61%	21
2025 Q3	$133M	Sell	579,407 -34,342	-6%	-$6.99M	0.63%	21
2025 Q2	$114M	Buy	613,749 +24,927	+4%	+$4.63M	0.56%	28
2025 Q1	$123M	Buy	588,822 +42,266	+8%	+$8.22M	0.71%	22
2024 Q4	$97.1M	Sell	546,556 -23,833	-4%	-$4.38M	0.57%	27
2024 Q3	$112M	Sell	570,389 -8,469	-1%	-$1.58M	0.65%	23
2024 Q2	$99.1M	Sell	578,858 -26,792	-4%	-$4.44M	0.6%	24
2024 Q1	$110M	Buy	+605,650	New	+$104M	0.66%	24

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Resona Asset Management's ABBV Position: Q2 2026 in Review

Resona Asset Management reduced its AbbVie (ABBV) stake by 7.1% in Q2 2026, selling an estimated $8.63M and leaving 525,318 shares worth $132M. The position accounts for 0.62% of the portfolio, ranked #26.

Resona Asset Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $133M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Resona Asset Management held 525,318 shares of AbbVie worth $132M as of Q2 2026.
Resona Asset Management sold 40,090 AbbVie shares in Q2 2026, an estimated $8.63M.
AbbVie made up 0.62% of Resona Asset Management's portfolio in Q2 2026, its #26 holding.
Resona Asset Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
Resona Asset Management's AbbVie position peaked at $133M in Q3 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.